Suchergebnisse - "Chu, Liuxiang"

PubPharm (18)

1

Tumor microenvironment-responsive micelles assembled from a prodrug of mitoxantrone and 1-methyl tryptophan for enhanced chemo-immunotherapy

enthalten in: Drug delivery | 2023

von Wang, R. | Li, N. | Zhang, T. | +5

2

Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity

enthalten in: Drug delivery | 2023

von Zhang, T. | Li, N. | Wang, R. | +5

3

Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-β1 blockade

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2023

von Li, N. | Zhang, T. | Wang, R. | +4

4

Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study

enthalten in: Molecular pharmaceutics | 2022

von Yu, Y. | Wang, A. | Wang, S. | +8

5

Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration

enthalten in: Frontiers in pharmacology | 2022

von Wang, S. | Yu, Y. | Wang, A. | +10

6

Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study

enthalten in: Journal of pharmaceutical sciences | 2021

von Yu, Y. | Wang, L. | Han, J. | +6

7

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease

enthalten in: Drug delivery | 2019

von Tang, S. | Wang, A. | Yan, X. | +8

8

Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation

enthalten in: Pharmaceutical development and technology | 2019

von Wang, A. | Yan, X. | Liang, R. | +4

9

Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption

enthalten in: Molecular pharmaceutics | 2019

von Song, Y. | Shi, Y. | Zhang, L. | +9

10

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease

enthalten in: Drug delivery | 2019

von Tang, S. | Wang, A. | Yan, X. | +8